Utility of PCA3 and TMPRSS2:ERG urinary biomarkers in African American men undergoing prostate biopsy.

Authors

null

Allison H. Feibus

Tulane University School of Medicine, New Orleans, LA

Allison H. Feibus , A. Oliver Sartor , Krishnarao Moparty , Michael W. Kattan , Kevin M. Chagin , Elisa M. Ledet , Justin Levy , Benjamin Lee , Raju Thomas , Jonathan L. Silberstein

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 126)

DOI

10.1200/jco.2016.34.2_suppl.126

Abstract #

126

Poster Bd #

F20

Abstract Disclosures

Similar Posters

Poster

2015 Genitourinary Cancers Symposium

Clinical performance of PCA3 and TMPRSS2:ERG urinary biomarkers for African American men undergoing prostate biopsy.

Clinical performance of PCA3 and TMPRSS2:ERG urinary biomarkers for African American men undergoing prostate biopsy.

First Author: Allison H. Feibus

First Author: Pierre-Jean Lamy

First Author: Cameron J Britton